首页 > 最新文献

Seminars in Thoracic and Cardiovascular Surgery最新文献

英文 中文
Masthead (copyright and information page) 刊头(版权和信息页)
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/S1043-0679(24)00034-0
{"title":"Masthead (copyright and information page)","authors":"","doi":"10.1053/S1043-0679(24)00034-0","DOIUrl":"https://doi.org/10.1053/S1043-0679(24)00034-0","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Page II"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141242780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary: Old Data Provide New Insights Into the Therapeutic Benefit of Adjuvant Chemotherapy in Non-Small Cell Lung Cancer 评论:旧数据为非小细胞肺癌辅助化疗的治疗效果提供了新见解。
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.11.006
Kyle G. Mitchell MD MSc, Mara B. Antonoff MD
{"title":"Commentary: Old Data Provide New Insights Into the Therapeutic Benefit of Adjuvant Chemotherapy in Non-Small Cell Lung Cancer","authors":"Kyle G. Mitchell MD MSc, Mara B. Antonoff MD","doi":"10.1053/j.semtcvs.2022.11.006","DOIUrl":"10.1053/j.semtcvs.2022.11.006","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 271-272"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40695738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AATS 2022 Virtual Annual Meeting AATS 2022 虚拟年会。
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.08.020
{"title":"AATS 2022 Virtual Annual Meeting","authors":"","doi":"10.1053/j.semtcvs.2022.08.020","DOIUrl":"10.1053/j.semtcvs.2022.08.020","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 240-241"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Closure of Left Atrial Appendage Has no Effect on Thromboembolic Rates after Mitral Valve Repair in Patients in Sinus Rhythm 关闭左心房附壁对窦性心律患者二尖瓣修复术后血栓栓塞率无影响
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.10.008
Maria Ascaso MD, Carolyn M. David BN, Chun-Po Steve Fan PhD, Sudipta Saha PhD, Tirone E. David MD

Closure of the left atrial appendage (LAA) reduces the rates of TIA/stroke in patients in atrial fibrillation (AF) but its role in patients in sinus rhythm who undergo mitral valve repair (MV) for leaflet prolapse remains unknown. This study examined the effects of closing the LAA in TIA/stroke after MV repair. Our database on patients who had MV repair for leaflet prolapse from 2000 through 2019 was reviewed. After excluding patients at higher risk of TIA/stroke, 1050 patients in sinus rhythm were entered into the study: 781 with open LAA and 269 with surgically closed LAA. Using a propensity score analysis to compensate from clinical differences, 267 pairs of patients with open and closed LAA were matched. Follow-up was truncated at 5 years because routine closure of the LAA was performed only during recent years. The cumulative incidence of TIA/stroke at 5 years in the entire cohort was 2.7% [95% CI 1.9, 4.0]; it was 2.9% [95% CI 1.9, 4.4] in patients with open LAA,and 1.8% [95% CI 0.7, 4.9] in patients with closed LAA (P = 0.53). In the matched cohorts, the cumulative incidences of TIA/stroke did not differ significantly (match-adjusted HR [95% CI] = 0.80 [0.21, 2.98], P = 0.74), and multivariable Cox proportional hazard regression analysis also confirmed no difference in the risk of TIA/stroke between the 2 groups (regression-adjusted HR [95% CI] = 0.58 [0.12, 2.9], P = 0.47). This study failed to show a reduction in the risk of TIA/stroke by closing the LAA in patients in sinus rhythm (Figure 6). Closure of the LAA during MV repair warrants a larger and more rigorous study.

关闭左心房附壁(LAA)可降低心房颤动(AF)患者的 TIA/中风发生率,但其在因瓣叶脱垂而接受二尖瓣修复术(MV)的窦性心律患者中的作用尚不清楚。本研究探讨了在二尖瓣修复术后关闭 LAA 对 TIA/中风的影响。我们对 2000 年至 2019 年期间因瓣叶脱垂接受二尖瓣修复术的患者数据库进行了回顾。在排除了 TIA/中风风险较高的患者后,1050 名窦性心律的患者被纳入研究:其中 781 人患有开放性 LAA,269 人患有手术封闭性 LAA。通过倾向评分分析来弥补临床差异,267 对开放性和闭合性 LAA 患者进行了配对。由于近几年才开始常规关闭 LAA,因此随访时间以 5 年为限。整个队列中 5 年的 TIA/ 卒中累积发生率为 2.7% [95% CI 1.9, 4.0];开放式 LAA 患者为 2.9% [95% CI 1.9, 4.4],封闭式 LAA 患者为 1.8% [95% CI 0.7, 4.9](P = 0.53)。在配对队列中,TIA/卒中的累积发病率没有显著差异(配对调整 HR [95% CI] = 0.80 [0.21, 2.98],P = 0.74),多变量 Cox 比例危险回归分析也证实两组之间的 TIA/ 卒中风险没有差异(回归调整 HR [95% CI] = 0.58 [0.12, 2.9],P = 0.47)。该研究未能显示窦性心律患者关闭 LAA 可降低 TIA/卒中风险(图 6)。在中风修复过程中关闭 LAA 需要进行更大规模、更严格的研究。
{"title":"Closure of Left Atrial Appendage Has no Effect on Thromboembolic Rates after Mitral Valve Repair in Patients in Sinus Rhythm","authors":"Maria Ascaso MD,&nbsp;Carolyn M. David BN,&nbsp;Chun-Po Steve Fan PhD,&nbsp;Sudipta Saha PhD,&nbsp;Tirone E. David MD","doi":"10.1053/j.semtcvs.2022.10.008","DOIUrl":"10.1053/j.semtcvs.2022.10.008","url":null,"abstract":"<div><p><span><span>Closure of the left atrial appendage (LAA) reduces the rates of TIA/stroke in patients in atrial fibrillation (AF) but its role in patients in </span>sinus rhythm<span> who undergo mitral valve repair (MV) for leaflet prolapse remains unknown. This study examined the effects of closing the LAA in TIA/stroke after MV repair. Our database on patients who had MV repair for leaflet prolapse from 2000 through 2019 was reviewed. After excluding patients at higher risk of TIA/stroke, 1050 patients in sinus rhythm were entered into the study: 781 with open LAA and 269 with surgically closed LAA. Using a propensity score analysis to compensate from clinical differences, 267 pairs of patients with open and closed LAA were matched. Follow-up was truncated at 5 years because routine closure of the LAA was performed only during recent years. The cumulative incidence of TIA/stroke at 5 years in the entire cohort was 2.7% [95% CI 1.9, 4.0]; it was 2.9% [95% CI 1.9, 4.4] in patients with open LAA,and 1.8% [95% CI 0.7, 4.9] in patients with closed LAA (</span></span><em>P</em> = 0.53). In the matched cohorts, the cumulative incidences of TIA/stroke did not differ significantly (match-adjusted HR [95% CI] = 0.80 [0.21, 2.98], <em>P</em><span> = 0.74), and multivariable Cox proportional hazard regression analysis also confirmed no difference in the risk of TIA/stroke between the 2 groups (regression-adjusted HR [95% CI] = 0.58 [0.12, 2.9], </span><em>P</em> = 0.47). This study failed to show a reduction in the risk of TIA/stroke by closing the LAA in patients in sinus rhythm (Figure 6). Closure of the LAA during MV repair warrants a larger and more rigorous study.</p></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 150-157"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9662810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Operating Room Versus Intensive Care Unit Extubation Within 6 Hours After On-Pump Cardiac Surgery: Early Results and Hospital Costs 泵上心脏手术后 6 小时内在手术室拔管与在重症监护室拔管的对比:早期结果和医院成本。
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.09.013
Andrew D. Hawkins MD , Raymond J. Strobel MD, MSc , J. Hunter Mehaffey MD, MSc , Robert B. Hawkins MD, MSc , Evan P. Rotar MD, MS , Andrew M. Young MD , Leora T. Yarboro MD , Kenan Yount MD, MBA , Gorav Ailawadi MD, MBA , Mark Joseph MD , Mohammed Quader MD , Nicholas R. Teman MD

Time-directed extubation (fast-track) protocols may decrease length of stay and cost but data on operating room (OR) extubation is limited. The objective of this study was to compare the outcomes of extubation in the OR versus fast-track extubation within 6 hours of leaving the operating room. Patients undergoing nonemergent STS index cases (2011–2021) who were extubated within 6 hours were identified from a regional STS quality collaborative. Patients were stratified by extubation in the OR versus fast track. Propensity score matching (1:n) was performed to balance baseline differences. Of the 24,962 patients, 498 were extubated in the OR. After matching, 487 OR extubation cases and 899 fast track cases were well balanced. The rate of reintubation was higher for patients extubated in the OR [21/487 (4.3%) vs 16/899 (1.8%), P = 0.008] as was the incidence of reoperation for bleeding [12/487 (2.5%) vs 8/899 (0.9%), P = 0.03]. There was no significant difference in the rate of any reoperation [16/487 (3.3%) vs 15/899 (1.6%), P = 0.06] or operative mortality [4/487 (0.8%) vs 6/899 (0.6%), P = 0.7]. OR extubation was associated with shorter hospital length of stay (5.6 vs 6.2 days, P < 0.001) and lower total cost of admission ($29,602 vs $31,565 P < 0.001). OR extubation is associated with a higher postoperative risk of reintubation and reoperation due to bleeding, but lower resource utilization.Future research exploring predictors of extubation readiness may be required prior to widespread adoption of this practice.

时间定向拔管(快速通道)方案可缩短住院时间并降低费用,但有关手术室拔管的数据却很有限。本研究旨在比较手术室内拔管与离开手术室后 6 小时内快速拔管的结果。从地区 STS 质量合作组织中筛选出在 6 小时内拔管的非急诊 STS 指数病例(2011-2021 年)患者。患者按在手术室拔管与快速通道拔管进行分层。进行倾向评分匹配(1:n)以平衡基线差异。在 24962 名患者中,有 498 人在手术室拔管。经过匹配后,487 例手术室拔管病例和 899 例快速通道病例达到了很好的平衡。在手术室拔管的患者再次插管率更高[21/487 (4.3%) vs 16/899 (1.8%),P = 0.008],因出血再次手术的发生率也更高[12/487 (2.5%) vs 8/899 (0.9%),P = 0.03]。再次手术率[16/487(3.3%) vs 15/899(1.6%),P = 0.06]或手术死亡率[4/487(0.8%) vs 6/899(0.6%),P = 0.7]无明显差异。手术后拔管可缩短住院时间(5.6 天 vs 6.2 天,P < 0.001),降低住院总费用(29,602 美元 vs 31,565 美元,P < 0.001)。手术室拔管与较高的术后再次插管风险和因出血而再次手术相关,但资源利用率较低。
{"title":"Operating Room Versus Intensive Care Unit Extubation Within 6 Hours After On-Pump Cardiac Surgery: Early Results and Hospital Costs","authors":"Andrew D. Hawkins MD ,&nbsp;Raymond J. Strobel MD, MSc ,&nbsp;J. Hunter Mehaffey MD, MSc ,&nbsp;Robert B. Hawkins MD, MSc ,&nbsp;Evan P. Rotar MD, MS ,&nbsp;Andrew M. Young MD ,&nbsp;Leora T. Yarboro MD ,&nbsp;Kenan Yount MD, MBA ,&nbsp;Gorav Ailawadi MD, MBA ,&nbsp;Mark Joseph MD ,&nbsp;Mohammed Quader MD ,&nbsp;Nicholas R. Teman MD","doi":"10.1053/j.semtcvs.2022.09.013","DOIUrl":"10.1053/j.semtcvs.2022.09.013","url":null,"abstract":"<div><p><span>Time-directed extubation<span> (fast-track) protocols may decrease length of stay and cost but data on operating room (OR) extubation is limited. The objective of this study was to compare the outcomes of extubation in the OR versus fast-track extubation within 6 hours of leaving the operating room. Patients undergoing nonemergent STS index cases (2011–2021) who were extubated within 6 hours were identified from a regional STS quality collaborative. Patients were stratified by extubation in the OR versus fast track. Propensity score matching (1:n) was performed to balance baseline differences. Of the 24,962 patients, 498 were extubated in the OR. After matching, 487 OR extubation cases and 899 fast track cases were well balanced. The rate of reintubation was higher for patients extubated in the OR [21/487 (4.3%) vs 16/899 (1.8%), </span></span><em>P</em><span> = 0.008] as was the incidence of reoperation for bleeding [12/487 (2.5%) vs 8/899 (0.9%), </span><em>P</em> = 0.03]. There was no significant difference in the rate of any reoperation [16/487 (3.3%) vs 15/899 (1.6%), <em>P</em><span> = 0.06] or operative mortality [4/487 (0.8%) vs 6/899 (0.6%), </span><em>P</em> = 0.7]. OR extubation was associated with shorter hospital length of stay (5.6 vs 6.2 days, <em>P</em> &lt; 0.001) and lower total cost of admission ($29,602 vs $31,565 <em>P</em> &lt; 0.001). OR extubation is associated with a higher postoperative risk of reintubation and reoperation due to bleeding, but lower resource utilization.Future research exploring predictors of extubation readiness may be required prior to widespread adoption of this practice.</p></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 195-208"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9539405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary: The Many Shades of Gradient After Repair of Tetralogy of Fallot 评论:法洛氏四联症修复后的多种渐变。
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2023.01.002
Sitaram M. Emani MD
{"title":"Commentary: The Many Shades of Gradient After Repair of Tetralogy of Fallot","authors":"Sitaram M. Emani MD","doi":"10.1053/j.semtcvs.2023.01.002","DOIUrl":"10.1053/j.semtcvs.2023.01.002","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Page 250"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9378059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage Non-Small Cell Lung Cancer: A Multicenter Study 早期非小细胞肺癌放射学与病理学肿瘤大小的差异:一项多中心研究。
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.12.001
Atsushi Kamigaichi MD , Yasuhiro Tsutani MD, PhD , Takahiro Mimae MD, PhD , Yoshihiro Miyata MD, PhD , Hiroyuki Adachi MD, PhD , Yoshihisa Shimada MD, PhD , Yukio Takeshima MD, PhD , Hiroyuki Ito MD, PhD , Norihiko Ikeda MD, PhD , Morihito Okada MD, PhD

Discrepancies between radiological whole tumor size (RTS) and pathological whole tumor size (PTS) are sometimes observed. Unexpected pathological upsize may lead to insufficient margins during procedures like sub lobar resections. Therefore, this study aimed to investigate the current status of these discrepancies and identify factors resulting in pathological upsize in patients with early-stage non-small cell lung cancer (NSCLC). Data from a multicenter database of 3092 patients with clinical stage 0-IA NSCLC who underwent pulmonary resection were retrospectively analyzed. Differences between the RTS and PTS were evaluated using Pearson's correlation analysis and Bland-Altman plots. Unexpected pathological upsize was defined as an upsize of ≥1 cm when compared to the RTS, and the predictive factors of this upsize were identified based on multivariable analyses. The RTS and PTS showed a positive linear relationship (r = 0.659), and the RTS slightly overestimated the PTS. The Bland-Altman plot showed 131 of 3092 (5.2%) cases were over the upper 95% limits of agreement. In multivariable analyses, a maximum standardized uptake value (SUVmax) of the primary tumor on 18-fluoro-2-deoxyglucose positron emission tomography/computed tomography (odds ratio [OR], 1.070; 95% confidence interval [CI], 1.035−1.107; P < 0.001) and the adenocarcinoma histology (OR, 1.899; 95% CI, 1.071−3.369; P =0.049) were independent predictors of unexpected pathological upsize. More of the adenocarcinomas with pathological upsize were moderately or poorly differentiated, when compared to those without. The RTS tends to overestimate the PTS; however, care needs to be taken regarding unexpected pathological upsize, especially in adenocarcinomas with a high SUVmax.

有时会发现放射学全肿瘤大小(RTS)和病理学全肿瘤大小(PTS)之间存在差异。在进行肺叶下切除等手术时,意外的病理增大可能会导致边缘不足。因此,本研究旨在调查这些差异的现状,并确定导致早期非小细胞肺癌(NSCLC)患者病理大小增大的因素。研究人员回顾性分析了多中心数据库中 3092 例接受肺切除术的临床 0-IA 期 NSCLC 患者的数据。采用皮尔逊相关分析和布兰德-阿尔特曼图评估了RTS和PTS之间的差异。与RTS相比,意外病理增大定义为增大≥1厘米,并根据多变量分析确定了这种增大的预测因素。RTS 和 PTS 呈正线性关系(r = 0.659),RTS 略微高估了 PTS。Bland-Altman 图显示,3092 个病例中有 131 个(5.2%)超过了 95% 的一致上限。在多变量分析中,18-氟-2-脱氧葡萄糖正电子发射断层扫描/计算机断层扫描显示的原发肿瘤最大标准化摄取值(SUVmax)(几率比[OR],1.070;95% 置信区间[CI],1.035-1.107;P <0.001)和腺癌组织学(OR,1.899;95% CI,1.071-3.369;P =0.049)是意外病理增大的独立预测因素。与未出现病理增大的腺癌相比,出现病理增大的腺癌中分化程度为中度或较差的腺癌更多。RTS倾向于高估PTS;然而,对于意外的病理增大,尤其是SUVmax较高的腺癌,需要谨慎对待。
{"title":"Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage Non-Small Cell Lung Cancer: A Multicenter Study","authors":"Atsushi Kamigaichi MD ,&nbsp;Yasuhiro Tsutani MD, PhD ,&nbsp;Takahiro Mimae MD, PhD ,&nbsp;Yoshihiro Miyata MD, PhD ,&nbsp;Hiroyuki Adachi MD, PhD ,&nbsp;Yoshihisa Shimada MD, PhD ,&nbsp;Yukio Takeshima MD, PhD ,&nbsp;Hiroyuki Ito MD, PhD ,&nbsp;Norihiko Ikeda MD, PhD ,&nbsp;Morihito Okada MD, PhD","doi":"10.1053/j.semtcvs.2022.12.001","DOIUrl":"10.1053/j.semtcvs.2022.12.001","url":null,"abstract":"<div><p><span><span>Discrepancies between radiological whole tumor size (RTS) and pathological whole tumor size (PTS) are sometimes observed. Unexpected pathological upsize may lead to insufficient margins during procedures like sub lobar resections. Therefore, this study aimed to investigate the current status of these discrepancies and identify factors resulting in pathological upsize in patients with early-stage non-small cell lung cancer (NSCLC). Data from a multicenter database of 3092 patients with clinical stage 0-IA NSCLC who underwent </span>pulmonary resection<span> were retrospectively analyzed. Differences between the RTS and PTS were evaluated using Pearson's correlation analysis and Bland-Altman plots. Unexpected pathological upsize was defined as an upsize of ≥1 cm when compared to the RTS, and the predictive factors of this upsize were identified based on multivariable analyses. The RTS and PTS showed a positive linear relationship (</span></span><em>r</em><span> = 0.659), and the RTS slightly overestimated the PTS. The Bland-Altman plot showed 131 of 3092 (5.2%) cases were over the upper 95% limits of agreement. In multivariable analyses, a maximum standardized uptake value (SUV</span><sub>max</sub>) of the primary tumor on 18-fluoro-2-deoxyglucose positron emission tomography/computed tomography (odds ratio [OR], 1.070; 95% confidence interval [CI], 1.035−1.107; <em>P</em> &lt; 0.001) and the adenocarcinoma histology (OR, 1.899; 95% CI, 1.071−3.369; <em>P</em> =0.049) were independent predictors of unexpected pathological upsize. More of the adenocarcinomas with pathological upsize were moderately or poorly differentiated, when compared to those without. The RTS tends to overestimate the PTS; however, care needs to be taken regarding unexpected pathological upsize, especially in adenocarcinomas with a high SUV<sub>max</sub>.</p></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 273-281"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10492897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shift in the Future of Cardiothoracic Surgery Applications: Holistic or Too Optimistic? 心胸外科应用的未来转变:全面还是过于乐观?
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.08.015
Ariadna Marrero BA , Lin Chen BA , Tara Karamlou MD, MSc , Alejandro Bribriesco MD
{"title":"Shift in the Future of Cardiothoracic Surgery Applications: Holistic or Too Optimistic?","authors":"Ariadna Marrero BA ,&nbsp;Lin Chen BA ,&nbsp;Tara Karamlou MD, MSc ,&nbsp;Alejandro Bribriesco MD","doi":"10.1053/j.semtcvs.2022.08.015","DOIUrl":"10.1053/j.semtcvs.2022.08.015","url":null,"abstract":"","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 213-214"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33458872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultra-Hybrid Repair: Open Thoracoabdominal Completion After Descending Stent Grafting 超混合修复术:降支支架移植术后的开放式胸腹完成术
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.10.004
Matthew A. Thompson BS, BA , Ashley M. Lowry MS, MEd , Francis Caputo MD , Douglas R. Johnston MD , Christopher Smolock MD , Patrick Vargo MD , Eugene H. Blackstone MD , Eric E. Roselli MD , Collaborators in the Cleveland Clinic Aorta Center

To characterize patient risk profiles and outcomes associated with staged ultra-hybrid repair of extensive aortic disease, in which open thoracoabdominal completion was performed after thoracic stent grafting. From 1/2006 to 1/2021, 92 patients underwent open thoracoabdominal repair of chronic dissection (n=58, 63%), degenerative aneurysm (n=28, 30%), endoleak (n=4, 4.3%), or symptomatic acute type B dissection (n=2, 2.2%) after descending thoracic stent grafting (69, 75%), frozen elephant trunk (5, 5%), or both (18, 20%). The surgical graft was sewn to the distal endovascular device in situ, reducing the extent of the open procedure and eliminating the need for hypothermic circulatory arrest. Mean age was 58±13 years, 89 (97%) were hypertensive, 38 (43%) had chronic obstructive pulmonary disease, 63 (72%) were smokers, 20 (24%) had a prior stroke, and 33 (36%) had a suspected or confirmed heritable aortic condition. Hospital mortality was 7.6% (n=7). Complications included dialysis (16, 20%), tracheostomy (8, 8.7%), stroke (5, 5.7%), and permanent paralysis (6, 6.9%). Survival at 1, 3, and 5 years was 80%, 71%, and 66%, respectively. Mortality was associated with higher blood urea nitrogen and longer distance between the distal endograft edge and proximal patent visceral vessel (P=0.004 and .01, respectively). Patients with extensive aortic disease undergoing open aortic repair after thoracic stent grafting are often young with chronic dissection, multiple comorbidities, or a heritable aortic condition. Success of staged ultra-hybrid operations demonstrates open and endovascular repair strategies are complementary, even when performed in a high-risk patient population.

目的:描述大面积主动脉疾病分期超混合修复术的患者风险概况和相关预后,其中在胸腔支架移植术后进行开胸腹腔修补术。从 2006 年 1 月 1 日至 2021 年 1 月 1 日,有 92 名患者在降胸支架移植术(69 例,占 75%)、冷冻象鼻支架移植术(5 例,占 5%)或两者同时进行(18 例,占 20%)后,对慢性夹层(58 例,占 63%)、退行性动脉瘤(28 例,占 30%)、内漏(4 例,占 4.3%)或无症状急性 B 型夹层(2 例,占 2.2%)进行了开胸腹腔修复。手术移植物与远端血管内设备原位缝合,减少了开放手术的范围,无需低体温循环抑制。平均年龄为 58±13 岁,89 人(97%)患有高血压,38 人(43%)患有慢性阻塞性肺病,63 人(72%)吸烟,20 人(24%)曾中风,33 人(36%)怀疑或证实患有遗传性主动脉疾病。住院死亡率为 7.6%(7 人)。并发症包括透析(16 例,20%)、气管造口术(8 例,8.7%)、中风(5 例,5.7%)和永久性瘫痪(6 例,6.9%)。1年、3年和5年的存活率分别为80%、71%和66%。死亡率与血尿素氮较高和远端内移植边缘与近端通畅内脏血管之间的距离较长有关(P=0.004 和 0.01)。在胸腔支架移植术后接受开放式主动脉修复术的大面积主动脉疾病患者通常比较年轻,患有慢性夹层、多种合并症或遗传性主动脉疾病。分期超混合手术的成功表明,即使在高风险患者群体中进行手术,开放式和血管内修复策略也是互补的。
{"title":"Ultra-Hybrid Repair: Open Thoracoabdominal Completion After Descending Stent Grafting","authors":"Matthew A. Thompson BS, BA ,&nbsp;Ashley M. Lowry MS, MEd ,&nbsp;Francis Caputo MD ,&nbsp;Douglas R. Johnston MD ,&nbsp;Christopher Smolock MD ,&nbsp;Patrick Vargo MD ,&nbsp;Eugene H. Blackstone MD ,&nbsp;Eric E. Roselli MD ,&nbsp;Collaborators in the Cleveland Clinic Aorta Center","doi":"10.1053/j.semtcvs.2022.10.004","DOIUrl":"10.1053/j.semtcvs.2022.10.004","url":null,"abstract":"<div><p><span>To characterize patient risk profiles and outcomes associated with staged ultra-hybrid repair of extensive aortic disease<span>, in which open thoracoabdominal completion was performed after thoracic stent grafting. From 1/2006 to 1/2021, 92 patients underwent open thoracoabdominal repair of chronic dissection (n=58, 63%), degenerative aneurysm (n=28, 30%), endoleak (n=4, 4.3%), or symptomatic acute type B dissection (n=2, 2.2%) after descending thoracic stent grafting (69, 75%), frozen elephant trunk (5, 5%), or both (18, 20%). The surgical graft was sewn to the distal endovascular device </span></span><em>in situ</em><span>, reducing the extent of the open procedure and eliminating the need for hypothermic circulatory arrest. Mean age was 58±13 years, 89 (97%) were hypertensive, 38 (43%) had chronic obstructive pulmonary disease<span><span>, 63 (72%) were smokers, 20 (24%) had a prior stroke, and 33 (36%) had a suspected or confirmed heritable aortic condition. Hospital mortality was 7.6% (n=7). Complications included dialysis (16, 20%), tracheostomy (8, 8.7%), stroke (5, 5.7%), and permanent paralysis (6, 6.9%). Survival at 1, 3, and 5 years was 80%, 71%, and 66%, respectively. Mortality was associated with higher </span>blood urea nitrogen and longer distance between the distal endograft edge and proximal patent visceral vessel (</span></span><em>P</em><span>=0.004 and .01, respectively). Patients with extensive aortic disease undergoing open aortic repair after thoracic stent grafting are often young with chronic dissection, multiple comorbidities, or a heritable aortic condition. Success of staged ultra-hybrid operations demonstrates open and endovascular repair strategies are complementary, even when performed in a high-risk patient population.</span></p></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 137-147"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33512118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fate of the Right Ventricular Outflow Tract Following Valve-Sparing Repair of Tetralogy of Fallot 法洛氏四联症瓣膜剥除术后右室流出道的命运
IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1053/j.semtcvs.2022.12.002
Omar Toubat PhD , Winfield J. Wells MD , Vaughn A. Starnes MD , Subramanyan Ram Kumar MD, PhD

Valve-sparing repair (VSR) of tetralogy of Fallot (TOF) tends to result in higher residual right ventricular outflow tract (RVOT) gradients. We evaluated the progression and clinical implications of RVOT gradients following VSR of TOF. Demographic, clinical, and operative data were retrospectively collected from consecutive TOF patients who underwent VSR at our institution between 01/2010 and 06/2021. RVOT gradient, pulmonary valve annulus (PVA) diameter and Boston Z-scores were recorded from serial echocardiograms. Data are presented as median and interquartile range or number and percentage. A total of 156 children (boys 92, 59%) underwent VSR at 6.5 (4.9-8.4) months of age and 6.6 kg (5.6- 7.7) weight. There was 1 (0.6%) operative mortality. The remaining 155 patients were followed for 69.4 months (4-106.2). RVOT gradient was 2.4m/s (1.7-2.9) at discharge. It transiently increased, then declined and stabilized during follow-up. PVA Z-score was -1.7 (-3.1 to 0.5) at discharge and ‘grew’ to -0.8 (-1.7 to 0.4) at last follow-up. Freedom from RVOT re-intervention was 97%, 94% and 91% at 1, 5 and 10-year follow-up. Among 67 (43%) patients with PVA Z-score < -2, a similar RVOT gradient pattern was observed and freedom from RVOT re-intervention was 97%, 95% and 95% at 1, 5 and 8-year follow-up. Following VSR of TOF, RVOT gradients transiently increase and then fall as PVA growth catches up, resulting in durable intermediate outcomes. Patients with PVA Z-score < -2 demonstrated a similar pattern of hemodynamics in the RVOT and excellent freedom from reintervention.

法洛氏四联症(TOF)的保瓣修复(VSR)往往会导致较高的残留右室流出道(RVOT)梯度。我们评估了法洛氏四联症 VSR 术后 RVOT 梯度的进展和临床影响。我们回顾性地收集了2010年1月1日至2021年6月6日期间在本院接受VSR的连续TOF患者的人口统计学、临床和手术数据。连续超声心动图记录了 RVOT 梯度、肺动脉瓣环(PVA)直径和波士顿 Z 评分。数据以中位数和四分位数间距或人数和百分比表示。共有 156 名儿童(男孩 92 名,占 59%)在 6.5(4.9-8.4)个月大、体重 6.6 公斤(5.6-7.7)时接受了 VSR。手术死亡率为 1 例(0.6%)。其余 155 名患者的随访时间为 69.4 个月(4-106.2 个月)。出院时 RVOT 梯度为 2.4m/s (1.7-2.9)。在随访期间,该阶差出现短暂上升,随后下降并趋于稳定。出院时,PVA Z 评分为-1.7(-3.1 至 0.5),最后一次随访时 "增长 "至-0.8(-1.7 至 0.4)。在1年、5年和10年的随访中,不再接受RVOT再介入治疗的比例分别为97%、94%和91%。在 67 名(43%)PVA Z 评分<-2 的患者中,观察到了类似的 RVOT 梯度模式,随访 1 年、5 年和 8 年时无 RVOT 再介入的比例分别为 97%、95% 和 95%。TOF进行VSR后,RVOT梯度会短暂增加,然后随着PVA的生长而下降,从而获得持久的中期疗效。PVA Z-score小于-2的患者的RVOT血流动力学模式相似,且很好地避免了再次介入。
{"title":"Fate of the Right Ventricular Outflow Tract Following Valve-Sparing Repair of Tetralogy of Fallot","authors":"Omar Toubat PhD ,&nbsp;Winfield J. Wells MD ,&nbsp;Vaughn A. Starnes MD ,&nbsp;Subramanyan Ram Kumar MD, PhD","doi":"10.1053/j.semtcvs.2022.12.002","DOIUrl":"10.1053/j.semtcvs.2022.12.002","url":null,"abstract":"<div><p><span><span>Valve-sparing repair (VSR) of tetralogy of Fallot<span> (TOF) tends to result in higher residual right ventricular outflow tract (RVOT) gradients. We evaluated the progression and clinical implications of RVOT gradients following VSR of TOF. Demographic, clinical, and operative data were retrospectively collected from consecutive TOF patients who underwent VSR at our institution between 01/2010 and 06/2021. RVOT gradient, </span></span>pulmonary valve annulus (PVA) diameter and Boston Z-scores were recorded from serial </span>echocardiograms<span><span>. Data are presented as median and interquartile range or number and percentage. A total of 156 children (boys 92, 59%) underwent VSR at 6.5 (4.9-8.4) months of age and 6.6 kg (5.6- 7.7) weight. There was 1 (0.6%) operative mortality. The remaining 155 patients were followed for 69.4 months (4-106.2). RVOT gradient was 2.4m/s (1.7-2.9) at discharge. It transiently increased, then declined and stabilized during follow-up. PVA Z-score was -1.7 (-3.1 to 0.5) at discharge and ‘grew’ to -0.8 (-1.7 to 0.4) at last follow-up. Freedom from RVOT re-intervention was 97%, 94% and 91% at 1, 5 and 10-year follow-up. Among 67 (43%) patients with PVA Z-score &lt; -2, a similar RVOT gradient pattern was observed and freedom from RVOT re-intervention was 97%, 95% and 95% at 1, 5 and 8-year follow-up. Following VSR of TOF, RVOT gradients transiently increase and then fall as PVA </span>growth catches up<span>, resulting in durable intermediate outcomes. Patients with PVA Z-score &lt; -2 demonstrated a similar pattern of hemodynamics in the RVOT and excellent freedom from reintervention.</span></span></p></div>","PeriodicalId":48592,"journal":{"name":"Seminars in Thoracic and Cardiovascular Surgery","volume":"36 2","pages":"Pages 242-249"},"PeriodicalIF":2.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10061142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Seminars in Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1